Autolus Therapeutics (AUTL) Cash & Equivalents (2017 - 2026)
Autolus Therapeutics (AUTL) recorded Cash & Equivalents of $171.41 million in Q2 2026, up 38.4% from $123.83 million a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Autolus Therapeutics reported Cash & Equivalents of $104.13 million, down 54.2% from FY2024.
- Annual Cash & Equivalents has declined for three straight years, with a four-year compound annual growth rate of -23.9% (FY2021 to FY2025).
- Across earlier years, Cash & Equivalents came in at $227.38 million in FY2024 (-5.1%), $239.57 million in FY2023 (-37.4%), $382.44 million in FY2022 (+23.2%) and $310.34 million in FY2021.
- The Q2 2026 figure is the highest quarterly Cash & Equivalents since Q4 2024.
- On a year-over-year basis, Cash & Equivalents rose in two of the last seven quarters, with an average decline of 17.3%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 156.3% in Q3 2024, against a decline of 87.4% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Autolus Therapeutics | 468.91 Mn | -511.27 Mn | 23.31 Mn | 245.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 245.41 Mn |
| Jun 30, 2026 | 171.41 Mn |
| Mar 31, 2026 | 130.93 Mn |
| Dec 31, 2025 | 104.13 Mn |
| Sep 30, 2025 | 86.12 Mn |
| Jun 30, 2025 | 123.83 Mn |
| Mar 31, 2025 | 95.80 Mn |
| Dec 31, 2024 | 227.38 Mn |
| Sep 30, 2024 | 657.07 Mn |
| Jun 30, 2024 | 705.94 Mn |
| Mar 31, 2024 | 758.53 Mn |
| Dec 31, 2023 | 239.57 Mn |
| Sep 30, 2023 | 256.42 Mn |
| Jun 30, 2023 | 307.50 Mn |
| Mar 31, 2023 | 343.03 Mn |
| Dec 31, 2022 | 382.44 Mn |
| Sep 30, 2022 | 163.05 Mn |
| Jun 30, 2022 | 216.44 Mn |
| Mar 31, 2022 | 268.56 Mn |
| Dec 31, 2021 | 310.34 Mn |
API Access
Autolus Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();